Flc Capital Advisors Pfizer Inc Transaction History

Flc Capital Advisors

  • $507 Million
  • Q3 2025

A detailed history of Flc Capital Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Flc Capital Advisors holds 71,747 shares of PFE stock, worth $1.8 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
71,747
Previous 57,692 24.36%
Holding current value
$1.8 Million
Previous $1.4 Million 30.76%
% of portfolio
0.36%
Previous 0.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025
BUY
$23.29 - $25.88 $327,340 - $363,743
14,055 Added 24.36%
71,747 $1.83 Million
Q2 2025

Jul 29, 2025
SELL
$21.59 - $24.84 $17,228 - $19,822
-798 Reduced 1.36%
57,692 $1.4 Million
Q1 2025

May 05, 2025
BUY
$25.01 - $27.13 $272,083 - $295,147
10,879 Added 22.85%
58,490 $1.48 Million
Q4 2024

Jan 16, 2025
BUY
$24.8 - $30.19 $219,207 - $266,849
8,839 Added 22.8%
47,611 $1.26 Million
Q3 2024

Oct 16, 2024
BUY
$27.7 - $31.39 $153,901 - $174,402
5,556 Added 16.73%
38,772 $1.12 Million
Q2 2024

Jul 15, 2024
SELL
$25.26 - $29.6 $87,147 - $102,120
-3,450 Reduced 9.41%
33,216 $929,000
Q1 2024

May 03, 2024
BUY
$25.89 - $29.73 $59,961 - $68,854
2,316 Added 6.74%
36,666 $1.02 Million
Q4 2023

Jan 18, 2024
SELL
$26.13 - $33.94 $337,259 - $438,063
-12,907 Reduced 27.31%
34,350 $988,000
Q3 2023

Jan 18, 2024
SELL
$32.09 - $37.51 $238,685 - $278,999
-7,438 Reduced 13.6%
47,257 $1.57 Million
Q2 2023

Aug 11, 2023
SELL
$36.12 - $41.79 $137,544 - $159,136
-3,808 Reduced 6.51%
54,695 $2.01 Million
Q1 2023

Apr 26, 2023
SELL
$39.39 - $51.28 $137,155 - $178,556
-3,482 Reduced 5.62%
58,503 $2.39 Million
Q4 2022

Jan 27, 2023
SELL
$41.75 - $54.5 $82,372 - $107,528
-1,973 Reduced 3.08%
61,985 $3.18 Million
Q3 2022

Oct 14, 2022
SELL
$43.76 - $53.42 $132,155 - $161,328
-3,020 Reduced 4.51%
63,958 $2.8 Million
Q2 2022

Jul 27, 2022
SELL
$46.53 - $55.17 $81,241 - $96,326
-1,746 Reduced 2.54%
66,978 $3.51 Million
Q1 2022

Apr 25, 2022
SELL
$45.75 - $56.69 $77,409 - $95,919
-1,692 Reduced 2.4%
68,724 $3.56 Million
Q4 2021

Jan 26, 2022
SELL
$41.32 - $61.25 $58,633 - $86,913
-1,419 Reduced 1.98%
70,416 $4.16 Million
Q3 2021

Oct 13, 2021
SELL
$39.25 - $50.42 $89,529 - $115,008
-2,281 Reduced 3.08%
71,835 $3.09 Million
Q2 2021

Aug 12, 2021
SELL
$35.91 - $40.68 $3,267 - $3,701
-91 Reduced 0.12%
74,116 $2.9 Million
Q1 2021

Apr 23, 2021
BUY
$33.49 - $37.77 $489,958 - $552,575
14,630 Added 24.56%
74,207 $2.69 Million
Q4 2020

Feb 10, 2021
BUY
$33.47 - $42.56 $324,357 - $412,448
9,691 Added 19.43%
59,577 $2.19 Million
Q3 2020

Oct 23, 2020
BUY
$31.75 - $37.25 $296,767 - $348,175
9,347 Added 23.06%
49,886 $1.87 Million
Q2 2020

Jul 10, 2020
BUY
$30.12 - $36.54 $194,364 - $235,792
6,453 Added 18.93%
40,539 $1.4 Million
Q1 2020

Apr 09, 2020
BUY
$27.03 - $38.62 $128,122 - $183,058
4,740 Added 16.15%
34,086 $1.12 Million
Q4 2019

Jan 13, 2020
SELL
$32.92 - $37.36 $2,699 - $3,063
-82 Reduced 0.28%
29,346 $1.15 Million
Q3 2019

Oct 29, 2019
BUY
$32.49 - $42.13 $30,118 - $39,054
927 Added 3.25%
29,428 $1.06 Million
Q2 2019

Aug 05, 2019
BUY
$36.98 - $41.52 $187,007 - $209,966
5,057 Added 21.57%
28,501 $1.23 Million
Q1 2019

May 13, 2019
BUY
$37.5 - $41.2 $177,225 - $194,711
4,726 Added 25.25%
23,444 $996,000
Q4 2018

Feb 11, 2019
BUY
$38.47 - $43.86 $720,081 - $820,971
18,718 New
18,718 $817,000

Others Institutions Holding PFE

# of Institutions
3,354
Shares Held
3.57B
Call Options Held
87.2M
Put Options Held
106M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Flc Capital Advisors Portfolio

Follow Flc Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email